Exercise during colorectal cancer chemotherapy showed small benefits for fatigue and depression
Randomized trials suggested symptom improvements, while physical capacity, strength, pain, anxiety and quality of life showed no statistically significant benefits.
Based on the published abstract. The full paper may contain additional methods, results and limitations.
The 30-second takeaway
In the randomized trials, exercise programs reduced fatigue and depression scores during adjuvant chemotherapy, with effects the authors described as potentially small. Other measured outcomes, including physical capacity and quality of life, did not improve significantly. The findings do not establish that exercise benefits every symptom or is safe for every patient.
The abstract does not describe the comparison treatments, program lengths or individual exercise plans. Safety reporting was incomplete, so an absence of reported adverse events cannot establish safety.
What researchers found
Fatigue scores
Exercise versus randomized-trial comparison groups during adjuvant chemotherapy; standardized mean difference. Comparator treatments and assessment timing were not described.
Which studies supplied the result
The review accepted several research designs, including randomized trials and studies without comparison groups. The reported pooled symptom benefits came from the randomized trials, which should be distinguished from the broader collection.
Understanding the scale
Fatigue and depression were measured as scores. The standardized effect combines results recorded on different scales; it is not a percentage improvement, and the abstract does not report how many people felt meaningfully better.
The original publication
Effectiveness of exercise interventions in patients with colorectal cancer during adjuvant chemotherapy: a systematic review and meta-analysis.
Yanagisawa T, Okamoto T, Hayashi K
Support Care Cancer · 2026
- PubMed ID
- 41860634
- Record checked
AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.
One more question, understood.
Keep track of the research you’ve explored.